Marex Group plc (MRX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MRX currently has 72.9M outstanding shares. with moderate dilution risk from 17.8M authorized shares representing 24.4% potential dilution. The company has minimally diluted shareholders by 5.14% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 25, 2026 |
20-F filing | 72.9M shares outstanding |
73M | 18M |
| Apr 14, 2025 |
F-1 filing: This F-1 filing outlines an offering of 8,500,000 ordinary shares by selling shareholders, with an option for underwriters to purchase an additional 1,275,000 shares. The company will not receive any proceeds from the sale of shares in this offering. |
71M | 18M |
| Mar 21, 2025 |
20-F filing | 72.2M shares outstanding |
72M | 8.1M |
| Oct 21, 2024 |
F-1 filing: This F-1 filing includes information on ordinary shares offered by selling shareholders and an option to purchase additional ordinary shares, with 70,290,886 ordinary shares outstanding as of June 30, 2024. |
70M | 8.1M |
| Oct 15, 2024 |
F-1 filing: This is an F-1 filing for Marex Group plc, offering up to $600,000,000 in aggregate principal amount of senior notes on a continuous basis. |
N/A | 0 |
| Mar 26, 2024 |
F-1 filing: This F-1 filing relates to an offering of ordinary shares by the company and selling shareholders. It also includes information about the company's dividend policy, risk factors, and listing plans on Nasdaq under the symbol "MRX." |
N/A | 0 |